|
|
|
| home > white papers > Clinical Trials in Russia Orange Paper: Summary of Year 2013 - Synergy Research Group |
|
|
 WHITE PAPERS |
|
Synergy Research Group
|
|
Clinical Trials in Russia Orange Paper: Summary of Year 2013
|
|
Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials.
Sponsors mention the following reasons for conducting studies in Russia:
1. Fast patient enrollment due to the centralized medical infrastructure.
2. Nearly 100% patient retention
3. GCP trained and certified Investigative Sites generating high quality data
4.
Low cost: Average per patient cost is 60% to 70% below US and European
prices due to the low cost of Investigators and the high concentration
of patients in therapeutically aligned medical centers
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
DoKaSch to provide cooling containers for El Al for pharma transport
El Al Israel Airlines has signed a master rental agreement with DoKaSch Temperature Solutions for the usage of ‘Opticooler’ containers. The airline will benefit from the active cooling container for its pharmaceutical shipments to and from Israel, DoKaSch said, being able to safely transport temperature-sensitive products to and from its headquarters at Ben Gurion Airport in the belly of its passenger fleet as well as a dedicated cargo aircraft.
More info >> |
|
 |
White Papers |
 |
|
Quality Systems Guide
Research Quality Association
This guide concentrates on the core, underlying principles of quality that are pivotal – explicitly or implicitly – to all quality management standards that impact on research and development.
More info >> |
|
|
|
